Advisors Asset Management Inc. Boosts Stock Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Advisors Asset Management Inc. increased its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 2.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 118,273 shares of the real estate investment trust’s stock after purchasing an additional 3,041 shares during the quarter. Advisors Asset Management Inc.’s holdings in Omega Healthcare Investors were worth $4,814,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in OHI. Daiwa Securities Group Inc. grew its holdings in Omega Healthcare Investors by 1,030.8% in the 2nd quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust’s stock valued at $32,384,000 after buying an additional 861,907 shares during the period. Marshall Wace LLP purchased a new stake in Omega Healthcare Investors in the 2nd quarter valued at about $20,962,000. BROOKFIELD Corp ON purchased a new stake in Omega Healthcare Investors in the 1st quarter valued at about $16,446,000. Dimensional Fund Advisors LP grew its holdings in Omega Healthcare Investors by 7.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock valued at $127,831,000 after buying an additional 272,299 shares during the period. Finally, Sei Investments Co. grew its holdings in Omega Healthcare Investors by 150.8% in the 2nd quarter. Sei Investments Co. now owns 298,761 shares of the real estate investment trust’s stock valued at $10,233,000 after buying an additional 179,623 shares during the period. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Insider Buying and Selling

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This represents a 10.96 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by corporate insiders.

Omega Healthcare Investors Stock Performance

Omega Healthcare Investors stock opened at $40.17 on Friday. The stock’s 50 day moving average price is $40.64 and its 200 day moving average price is $36.88. The firm has a market capitalization of $10.84 billion, a PE ratio of 29.53, a price-to-earnings-growth ratio of 1.25 and a beta of 0.99. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. Omega Healthcare Investors, Inc. has a one year low of $27.53 and a one year high of $44.42.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were given a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 6.67%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 197.06%.

Analysts Set New Price Targets

Several analysts have commented on the company. Berenberg Bank assumed coverage on Omega Healthcare Investors in a report on Friday, October 18th. They issued a “buy” rating and a $45.00 price target for the company. BNP Paribas raised Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective on the stock in a research note on Thursday, October 31st. Royal Bank of Canada lifted their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research note on Monday, November 11th. Scotiabank lifted their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research note on Monday, August 26th. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and issued a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, Omega Healthcare Investors currently has a consensus rating of “Hold” and a consensus target price of $40.00.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.